New treatment for enlarged prostate symptoms
Part of Kidney & urinary clinical trials.
This study tests a new treatment called INTUPRO for men with an enlarged prostate causing bothersome urinary symptoms. It aims to see if it can safely improve symptoms like difficulty starting urination or incomplete emptying.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 45 or older.
- Your prostate is larger than 30 grams (about the size of a walnut).
- You have moderate to severe urinary symptoms, like trouble starting or stopping, or feeling your bladder isn't empty.
- You are able to have MRI scans and are not allergic to the contrast dye used for them.
- You have not had radiation treatment to your pelvis or certain types of cancer (bladder, kidney).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two minimally invasive procedures to relieve urinary symptoms caused by an enlarged prostate. Both treatments aim to open the urethra without major surgery, and the goal is to improve your urine flow and reduce bothersome symptoms.
This trial tests a non-invasive treatment using high-intensity focused ultrasound (HIFU) to reduce prostate tissue that blocks urine flow. It may help men with moderate to severe urinary symptoms from an enlarged prostate who haven't had success with or can't take medication.
This study tests a new, minimally invasive procedure to relieve urinary symptoms caused by an enlarged prostate (benign prostatic hyperplasia or BPH). The procedure gently dilates (widens) the prostate to improve urine flow and reduce bothersome symptoms like frequent urination and weak stream.
This trial tests a newer, minimally invasive treatment (high-frequency irreversible electroporation) against standard treatments for an enlarged prostate causing urinary symptoms. The goal is to see if this approach relieves symptoms with fewer side effects.
This study compares two minimally invasive devices (iTind and UroLift) to treat urinary symptoms caused by an enlarged prostate. It is for men whose symptoms are bothersome enough to need treatment.
This trial tests a new minimally invasive procedure called irreversible electroporation (IRE)—which uses electrical pulses to treat prostate tissue—to relieve urinary symptoms caused by an enlarged prostate. The goal is to improve urinary flow and reduce bothersome symptoms without major surgery.
Hear when a new BPH trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.